Global Sleep Apnea Devices Market valued at $5.5 billion in 2021, is set to witness a decent growth of 7% by 2026

Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing (SDB). It is a partial or complete collapse of the upper airway caused by the relaxation of the muscles controlling the soft palate and tongue. The prevalence of OSA has been increasing steadily, and as per estimates, it affects ~3% to 20% of the general population.

Technological Innovations is driving the Sleep Apnea Devices Market Growth

The global sleep apnea devices market is a technology-driven market and is marked by constant product enhancements and market innovations. For instance,

  • In October, 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms.
  • In August 2021, Resmed, launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 includes new features such as Personal Therapy Assistant and Care Check-In designed to provide tailored guidance to PAP users, helping ease them into therapy and comfortable nightly use.

Shift Towards Home Sleep Apnea Test (HSAT) Triggers the Market Demand

The traditional way of sleep apnea testing required an overnight stay at a sleep lab. However, the trend is fast-changing now and home sleep tests are now growing in popularity. A home sleep apnea test (HSAT) is an overnight test that is conducted outside the hospital or sleep lab. These tests are conducted using a special device that measures sleep patterns during the night. HSATs cost less, generally require only a few monitors & straps, and can take place in the comfort of a person’s home.

A home sleep apnea test (HSAT) is financially more friendly. It costs ~ $200 to $600, which is relatively less than $800 to $3,000 for an overnight visit to a sleep lab. Also, insurers are increasingly requiring HSAT as a first step before paying for an in-lab sleep apnea test.” - Product Manager, Leading Sleep Apnea Diagnostic Device Manufacturer, United States

Organic and Inorganic Growth Strategies Adopted by Market Players to Establish Their Foothold in Sleep Apnea Devices Market

The sleep apnea devices market is marked by the presence of both established and emerging players. Players operating in the market adopt both organic and inorganic growth strategies such as new product launches, and partnerships to garner larger market share. For instance,

  • In December 2021, ZOLL® Medical Corporation, completed the acquisition of Itamar™ Medical Ltd., a medical device and digital health company that provides at-home testing for sleep apnea.
  • In February 2021, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea launched a new oral appliance - O2Vent Optima.

The global sleep apnea devices market is marked by the presence of top industry players such as ResMed, Philips Respironics, Fisher & Paykel Healthcare, SomnoMed, Itamar Medical, Inspire Medical Systems, Compumedics, Oventus Medical, Natus Medical, Drive DeVilbiss Healthcare, Whole You, BMC Medical, among others.

Get Customized Market Research Report on Sleep Apnea Devices Market @ https://meditechinsights.com/sleep-apnea-devices-market/

Comments

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027